Duration of anticoagulant therapy and VTE recurrence in patients with cancer

PURPOSE: Anticoagulant therapy for at least 3–6 months is currently recommended for treatment of venous thromboembolism (VTE) in patients with cancer, but the optimal duration of treatment is unknown. This study examines the association between the duration of anticoagulation treatment and VTE recur...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Support Care Cancer
Autori principali: Khorana, Alok A., McCrae, Keith R., Milentijevic, Dejan, Fortier, Jonathan, Nelson, Winnie W., Laliberté, François, Crivera, Concetta, Lefebvre, Patrick, Schein, Jeff
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6726708/
https://ncbi.nlm.nih.gov/pubmed/30734088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-4661-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi